Stocksigma LogoStocksigma Logo

Vilin Bio Med Convenes NCLT-Directed Meetings for Chemgenix Laboratories Merger

Pursuant to the NCLT Hyderabad Bench-I order dated 10th Sep'26, Vilin Bio Med Limited has convened meetings of its equity shareholders and creditors on

Vilin Bio Med Convenes NCLT-Directed Meetings for Chemgenix Laboratories Merger

Vilin Bio Med Ltd 路 Outcome 路 16 Sept 2026, 12:02 am

Vilin Bio Med Convenes NCLT-Directed Meetings for Chemgenix Laboratories Merger Pursuant to the NCLT Hyderabad Bench-I order dated 10th Sep'26, Vilin Bio Med Limited has convened meetings of its equity shareholders and creditors on 15th Oct'26 to approve the Scheme of Amalgamation with Chemgenix Laboratories Private Limited. The share swap ratio is fixed at 1:1, requiring the issuance of 96.90 lakh shares. Consequently, post-merger equity will increase to 2.49 crore shares, raising promoter holding from 56.65% to 73.49% and diluting public shareholding to 26.51%. Remote e-voting runs from 12th Oct'26 to 14th Oct'26.

Original exchange filing (PDF)

More announcements from Vilin Bio Med Ltd

All Vilin Bio Med Ltd announcements